Allergic bronchopulmonary aspergillosis: The hunt for a diagnostic serological marker in cystic fibrosis patients

Expert Review of Molecular Diagnostics

Volumn 9, Issue 2, 2009, Pages 157-164

  Hafen, Gaudenz M ^a   Hartl, Dominik ^b   Regamey, Nicolas ^c   Casaulta, Carmen ^c   Latzin, Philipp ^c,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Allergic bronchopulmonary aspergillosis; Cystic fibrosis; IgE; recombinant IgE; Serum marker; Thymus and activation regulated chemokine

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CCR4; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; BIOLOGICAL MARKER;

ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; HUMAN; IMMUNE RESPONSE; LUNG FIBROSIS; LUNG INFILTRATE; NONHUMAN; PATHOPHYSIOLOGY; PRICK TEST; REVIEW; SEROLOGY; TH1 CELL; TH2 CELL; BLOOD; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; LUNG ASPERGILLOSIS;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BIOLOGICAL MARKERS; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 66549116733     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.9.2.157     Document Type: Review

References (65)

1. Gibson PG. Allergic bronchopulmonary aspergillosis. Semin. Respir. Crit. Care Med. 27(2), 185-191 (2006).
2. Greenberger PA. Allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 110(5), 685-692 (2002).
3. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 174(11), 1211-1220 (2006).
4. Virnig C, Bush RK. Allergic bronchopulmonary aspergillosis: a US perspective. Curr. Opin. Pulm. Med. 13(1), 67-71 (2007).
5. de Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr. Respir. Rev. 7(1), 67-72 (2006).
6. Stevens DA, Moss RB, Kurup VP et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis. 37(Suppl. 3), S225-S264 (2003).
7. Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med. Mycol. 30, 1-7 (2008).
8. Hartl D. Immunological mechanisms behind the cystic fibrosis-ABPA link. Med. Mycol. 24, 1-9 (2008).
9. Meier A, Kirschning CJ, Nikolaus T et al. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell. Microbiol. 5(8), 561-570 (2003).
10. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277(42), 39320-39326 (2002).
11. Braedel S, Radsak M, Einsele H et al. Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptors 2 and 4. Br. J. Haematol. 125(3), 392-399 (2004).
12. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277(42), 39320-39326 (2002).
13. Blease K, Kunkel SL, Hogaboam CM. IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflamm. Res. 50(11), 552-560 (2001).
14. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 172(5), 530-551 (2005).
15. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8(3), 183-192 (2008).
16. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am. Rev. Respir. Dis. 120(4), 863-873 (1979).
17. Cunningham S, Madge SL, Dinwiddie R. Survey of criteria used to diagnose allergic bronchopulmonary aspergillosis in cystic fibrosis. Arch. Dis. Child. 84(1), 89 (2001).
18. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest 116(3), 639-646 (1999).
19. Mastella G, Rainisio M, Harms HK et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur. Respir. J. 16(3), 464-471 (2000).
20. Ratjen F, Doring G. Cystic fibrosis. Lancet 361(9358), 681-689 (2003).
21. Burns JL, Emerson J, Stapp JR et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27(1), 158-163 (1998).
22. Skov M, McKay K, Koch C, Cooper PJ. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respir. Med. 99(7), 887-893 (2005).
23. Longbottom JL. Allergic bronchopulmonary aspergillosis: reactivity of IgE and IgG antibodies with antigenic components of Aspergillus fumigatus (IgE/IgG antigen complexes). J. Allergy Clin. Immunol. 72(6), 668-675 (1983).
24. Nikolaizik WH, Crameri R, Blaser K, Schoni MH. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int. Arch. Allergy Immunol. 111(4), 403-408 (1996).
25. Vailes L, Sridhara S, Cromwell O et al. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J. Allergy Clin. Immunol. 107(4), 641-646 (2001).
26. Kurup VP, Kumar A. Immunodiagnosis of aspergillosis. Clin. Microbiol. Rev. 4(4), 439-456 (1991).
27. Kurup VP. Aspergillus antigens: which are important? Med. Mycol. 43(Suppl. 1), S189-S196 (2005).
28. Kurup VP, Banerjee B, Hemmann S et al. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin. Exp. Allergy 30(7), 988-993 (2000).
29. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int. Arch. Allergy Immunol. 115(2), 99-114 (1998).
30. Nikolaizik WH, Moser M, Crameri R et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am. J. Respir. Crit. Care Med. 152(2), 634-639 (1995).
31. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int. Immunol. 10(8), 1211-1216 (1998).
32. Banerjee B, Greenberger PA, Fink JN, Kurup VP. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect. Immun. 66(11), 5175-5182 (1998).
33. Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R. Di fferential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur. J. Immunol. 28(4), 1155-1160 (1998).
34. Crameri R, Lidholm J, Gronlund H et al. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System. Clin. Exp. Allergy 26(12), 1411-1419 (1996).
35. Knutsen AP, Hutcheson PS, Slavin RG, Kurup VP. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59(2), 198-203 (2004).
36. Casaulta C, Fluckiger S, Crameri R, Blaser K, Schoeni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr. Allergy Immunol. 16(3), 217-225 (2005).
37. Skov M, Koch C, Reimert CM, Poulsen LK. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 55(1), 50-58 (2000).
38. Kurup VP, Knutsen AP, Moss RB, Bansal NK. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin. Mol. Allergy 4, 11 (2006).
39. Almeida MB, Bussamra MH, Rodrigues JC. ABPA diagnosis in cystic fibrosis patients: the clinical utility of IgE specific to recombinant Aspergillus fumigatus allergens. J. Pediatr. (Rio J.) 82(3), 215-220 (2006).
40. Hartl D, Griese M, Kappler M et al. Pulmonary T(h)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117(1), 204-211 (2006).
41. de Oliveira E, Giavina-Bianchi P, Fonseca LA, Franca AT, Kalil J. Allergic bronchopulmonary aspergillosis' diagnosis remains a challenge. Respir. Med. 101(11), 2352-2357 (2007).
42. Gautam P, Sundaram CS, Madan T et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin. Exp. Allergy 37(8), 1239-1249 (2007).
43. Kodzius R, Rhyner C, Konthur Z et al. Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays. Comb. Chem. High Throughput Screen 6(2), 147-154 (2003).
44. Glaser AG, Menz G, Kirsch AI et al. Auto- and cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis. Allergy 63 (12), 1617-1623 (2008).
45. Glaser AG, Limacher A, Fluckiger S et al. Analysis of the cross-reactivity and of the 1.5 A crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem. J. 396(1), 41-49 (2006).
46. Van Hoeyveld E, Dupont L, Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clin. Chem. 52(9), 1785-1793 (2006).
47. Hutcheson PS, Knutsen AP, Rejent AJ, Slavin RG. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 110(2), 363-366 (1996).
48. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 54(1), 44-50 (1999).
49. Skov M, Pandey JP, Pressler T, Hoiby N, Koch C. Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients. J. Cyst. Fibros. 3(3), 173-178 (2004).
50. Aberer W, Woltsche M, Woltsche-Kahr I, Kranke B. IgG antibodies typical for extrinsic allergic alveolitis - an inter- laboratory quality assessment. Eur. J. Med. Res. 6(11), 498-504 (2001).
51. Barton RC, Hobson RP, Denton M et al. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus. Diagn. Microbiol. Infect. Dis. 62(3), 287-291 (2008).
52. Ringer S, Hipler UC, Elsner P, Zintl F, Mainz J. Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Pediatr. Pulmonol. 42(4), 314-318 (2007).
53. Latzin P, Hartl D, Regamey N et al. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur. Respir. J. 31(1), 36-42 (2008).
54. Becker JW, Burke W, McDonald G et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 109(6), 1536-1540 (1996).
55. Schwartz RH, Hollick GE. Allergic bronchopulmonary aspergillosis (Abpa) with low serum IgE. Pediatr. Res. 15(4), 603 (1981).
56. Knutsen AP, Noyes B, Warrier MR, Consolino J. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL. Ann. Allergy Asthma Immunol. 95(5), 488-493 (2005).
57. Dorsaneo D, Borowitz D, Sharp J, Moss R. Allergic bronchopulmonary aspergillosis with normal serum IgE in a child with cystic fibrosis. Pediatric Asthma Allergy Immunol. 17(2), 146 (2004).
58. Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Frontiers Biosci. 8, E190-E196 (2003).
59. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J. Clin. Invest. 97(10), 2324-2331 (1996).
60. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunology Today 19(12), 568-574 (1998).
61. D'Ambrosio D, Iellem A, Bonecchi R et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161(10), 5111-5115 (1998).
62. Miyazaki E, Nureki S, Fukami T et al. Elevated levels of thymus- and activation- regu lated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am. J. Respir. Crit. Care Med. 165(8), 1125-1131 (2002).
63. Hartl D, Latzin P, Zissel G et al. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 173(12), 1370-1376 (2006).
64. Moss RB. Management of allergic aspergillosis. Curr. Allergy Asthma Report 8, 433-439 (2008).
65. Hartl D, Buckland KF, Hogaboam CM. Chemokines in allergic aspergillosis - from animal models to human lung diseases. Inflamm. Allergy Drug Targets 5(4), 219-228 (2006).